The American Journal of Medicine
Volume 123, Issue 5 , Pages 423-425 , May 2010

Cutaneous Amyloidosis: Similar, but Different

  • Erika Music, MD

      Affiliations

    • Department of Medicine, Division of Dermatology, John H. Stroger, Jr. Hospital of Cook County, Chicago, Ill
    • Corresponding Author InformationRequests for reprints should be addressed to Erika Music, MD, 1900 W. Polk Street, Administration Bldg. Rm. 519, Chicago, IL 60612
    • ,
  • Warren Piette, MD

      Affiliations

    • Department of Medicine, Division of Dermatology, John H. Stroger, Jr. Hospital of Cook County, Chicago, Ill
    • Department of Dermatology, Rush University Medical Center, Chicago, Ill

References 

  1. Black MM, Upjohn E, Albert S. Amyloidosis (Dermatology). In:  Bolognia JL, et al. editor. Philadelphia: Mosby Elsevier; 2008;p. 623–631
  2. Obici L, Perfetti V, Palladini G, et al. Clinical aspects of systemic amyloid disease. Biochem Biophys Acta. 2005;1:11–22
  3. Dember LM, Jaber BL. Dialysis-related amyloidosis: late finding or hidden epidemic?. Semin Dialysis. 2006;19:105–109
  4. Uenotsuchi T, Imafuku S, Nagata M, et al. Cutaneous and lingual papules as a sign of β2- microglobulin-derived amyloidosis in a long-term hemodialysis patient. Eur J Dermatol. 2003;13:393–395
  5. Ohashi K. Pathogenesis of β2-microglobulin amyloidosis. Pathol Int. 2001;51:1–10
  6. Pozzi C, Locatelli F. Kidney and liver involvement in monoclonal light chain disorders. Semin Nephrol. 2002;4:319–330
  7. Sato KC, Kumakiri M, Koizumi H, et al. Lichenoid skin lesions as a sign of β2-microglobulin-induced amyloidosis in a long-term haemodialysis patient. Br J Dermatol. 1993;128:686–689
  8. Shimizu S, Yasui C, Yasukawa K, et al. Subcutaneous nodules on the buttocks as a manifestation of dialysis-related amyloidosis: a clinicopathological entity?. Br J Dermatol. 2003;149:400–404
  9. Comenzo RL. Primary systemic amyloidosis. Curr Treat Options Oncol. 2000;1:83–89
  10. Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicines alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. NEJM. 1997;17:1202–1207
  11. Hakim RM, Wingard RLHusni, et al. The effect of membrane biocompatibility on plasma β2-microglobulin levels in chronic hemodialysis patients. J Am Soc Nephrol. 1996;7:472–478

 Parwathi ‘Uma' Paniker, MD, Section Editor

 Funding: None.

 Conflict of Interest: Neither author has any potential conflicts of interest to declare.

 Authorship: Both authors had access to the data and contributed to the writing of the manuscript.

PII: S0002-9343(10)00075-6

doi: 10.1016/j.amjmed.2010.01.009

The American Journal of Medicine
Volume 123, Issue 5 , Pages 423-425 , May 2010

Article Tools

* Image Usage & Resolution